Literature DB >> 17503314

[Socio-economical aspects, quality of life and state of knowledge in hepatitis B patients. Socio-economical aspects in hepatitis B].

C Niederau1, C Fischer, A Kautz.   

Abstract

BACKGROUND: Little is known about socio-economical consequences and information status of patients with chronic hepatitis B virus (HBV) infection. AIMS AND METHODS: The present study prospectively analyzed questionnaires about socio-economical consequences and information status including the SF12 quality-of-life analysis in HBV-infected subjects. Overall 1500 questionnaires were distributed by clinics, practioners, patient support groups and internet; 255 questionnaires were sent back. Results were compared with a recent study in 714 HCV infected patients (Z Gastroenterol 2006; 44: 305-317).
RESULTS: HBV-infected patients were younger (mean 46 vs. 52 years), more likely to be male (62 vs. 44%) and to come from abroad (30 vs. 9%) when compared with HCV-infected subjects. Only 1 and 4% of HBV- and HCV-infected subjects, respectively, considered the public information about hepatitis as good or very good, 73 and 77%, however, as bad or very bad. Mental and physical quality-of-life (SF12) was better in HBV- than in HCV-infected subjects, but reduced when compared with a sex- and age-matched general population (p < 0.001). Quality-of-life decreased with increases in HBV-DNA, fibrosis and inflammation. In both HBV- and HCV-infected subjects there were information deficits concerning the risks for infection; some of these were more pronounced in HBV-infected subjects when compared to HCV-infected ones. German subjects with HBV and HCV infection are in general well informed about their infection (73-87% knew ALT and histology results); however, HBV-infected subjects are less well informed in particular about viral load and HBeAg (59 and 30%) when compared with HCV infected subjects who knew HCV-RNA and genotype in 80-85%.
CONCLUSIONS: The information deficits about viral load are of concern for HBV-infected subjects because these data are more important in HBV than in HCV infection. This lack of information likely reflects a lack of attentiveness towards HBV-DNA levels by the patients' physician. Both HBV- and HCV-infected subjects have problems at work and with various insurances; both have a reduced quality-of-life which correlates with viral load and degree of inflammation and fibrosis. Both populations consider the public information status about viral hepatitis to be bad.

Entities:  

Mesh:

Year:  2007        PMID: 17503314     DOI: 10.1055/s-2007-963102

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  6 in total

1.  Assessment of quality of life in hepatitis B patients in Iran.

Authors:  Zary Nokhodian; Behrooz Ataei; Nazila Kassaian; Peyman Adibi; Ziba Farajzadegan
Journal:  Indian J Gastroenterol       Date:  2009 May-Jun

2.  Neuropsychological alterations in hepatitis C infection: the role of inflammation.

Authors:  Marco Senzolo; Sami Schiff; Cristina Maria D'Aloiso; Chiara Crivellin; Evangelos Cholongitas; Patrizia Burra; Sara Montagnese
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

3.  Chronic hepatitis C: treat or wait? Medical decision making in clinical practice.

Authors:  Claus Niederau; Dietrich Hüppe; Elmar Zehnter; Bernd Möller; Renate Heyne; Stefan Christensen; Rainer Pfaff; Arno Theilmeier; Ulrich Alshuth; Stefan Mauss
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 4.  Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.

Authors:  Salvatore Monaco; Sara Mariotto; Sergio Ferrari; Massimiliano Calabrese; Gianluigi Zanusso; Alberto Gajofatto; Domenico Sansonno; Franco Dammacco
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 5.  Hepatitis C virus infection and the brain.

Authors:  Karin Weissenborn; Anita B Tryc; Meike Heeren; Hans Worthmann; Henning Pflugrad; Georg Berding; Martin Bokemeyer; Hans L Tillmann; Annemarie Goldbecker
Journal:  Metab Brain Dis       Date:  2009-01-07       Impact factor: 3.584

6.  The epidemiology of Hepatitis B, C and D in Germany: A scoping review.

Authors:  Gyde Steffen; Ida Sperle; Siv Aina Leendertz; Navina Sarma; Sandra Beermann; Roma Thamm; Viviane Bremer; Ruth Zimmermann; Sandra Dudareva
Journal:  PLoS One       Date:  2020-03-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.